论文部分内容阅读
目的探讨单硝酸异山梨酯治疗冠状动脉粥样硬化性心脏病(CHD)合并心功能不全的临床疗效。方法选取2014年5月至2016年5月辽宁省铁岭市银州区医院收治的60例CHD合并心功能不全患者为研究对象,采用等距随机抽样法分为对照组(益心康泰胶囊治疗)及观察组(单硝酸异山梨酯治疗),各30例,比较两组患者的临床疗效。结果观察组患者治疗的总有效率为90.0%,明显高于对照组的76.7%,差异有统计学意义(P<0.05);疗程结束后两组患者N-末端脑钠肽原(NT-proBNP)、6分钟步行试验(6-MWT)、左心室舒张功能指标、血流变指标比较,差异均有统计学意义(均P<0.05)。结论单硝酸异山梨酯治疗CHD合并心功能不全疗效确切。
Objective To investigate the clinical efficacy of isosorbide mononitrate in the treatment of coronary atherosclerotic heart disease (CHD) with cardiac dysfunction. Methods From May 2014 to May 2016, 60 patients with CHD with cardiac insufficiency admitted to Yinzhou District Hospital of Tieling City, Liaoning Province were selected as subjects. Patients were randomly divided into control group (Yixin Kangtai Capsule) And observation group (isosorbide mononitrate treatment), each 30 cases, the clinical efficacy of two groups were compared. Results The total effective rate of observation group was 90.0%, which was significantly higher than that of the control group (76.7%), the difference was statistically significant (P <0.05). After the treatment, N-terminal proBNP ), 6-minute walking test (6-MWT), left ventricular diastolic function index and hemorrheological index (all P <0.05). Conclusion Isosorbide mononitrate treatment of CHD with cardiac dysfunction, the exact effect.